131 funding opportunities are listed in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest
Clinical Research Awards for Neurofibromatosis: Request for Letters of Intent
The Children’s Tumor Foundation announces a call for Letters of Intent for Clinical Research Awards of up to $100,000. Clinical Research Awards seeks broad-thinking novel ideas to conduct pilot clinical trials of candidate therapeutics for the treatment of tumors and other manifestations of NF1, NF2 and schwannomatosis; OR innovative studies ancillary or adjunct to clinical trials that - if successful - will contribute to the advancement of effective clinical therapies for neurofibromatosis.
Examples of projects encouraged may include but are not limited to: - Biomarker studies adjunct to an ongoing clinical trial (may be e.g. molecular, imaging or genetic biomarkers, or other novel outcome parameters) that may better inform on and ultimately help accelerate a clinical trial. - Preclinical/clinical collaborative studies (‘clinical co-trials’). Note however that all studies must include a clinical element – preclinical-only studies are not eligible. - Applications to fund pilot neurofibromatosis clinical trials are welcomed an encouraged.
It is anticipated that CTF will fund up to four Clinical Research Awards of up to $100,000 (including overheads/indirect costs).
Application Process and Timeline LOI’s due: September 15, 2010 Applicants notified: October 4, 2010
Successful LOIs will be invited to submit a full application.
Full applications due: November 15, 2010 Applicants notified: Mid-December 2010 Funding commences as early as: January 2011
Before submitting your LOI, you are strongly encouraged to contact me to discuss your idea.
Kim Hunter-Schaedle, Ph.D. Chief Scientific Officer Children's Tumor Foundation Khunter-schaedle@ctf.org Tel: 212-344-6633 x231
Nephrotic Syndrome Study Network (NEPTUNE) Career Development Fellowship
Deadline for application: November 2, 2010
Objectives: The NEPTUNE Career Development program is designed to support advanced post-doctoral and junior faculty trainees, or established investigators interested in redirecting their investigative focus, who are preparing to become independent investigators in clinical and translational research in human glomerular disease. Successful applicants will design and carry out an individually tailored program that combines a clearly defined training component with a mentored research experience that employs the unique resources of NEPTUNE.
• Eligibility:
o Clinical fellows (MD, MD/PhD, or equivalent degrees) who have completed their clinical training in nephrology or pathology or a subspecialty relevant to the study of glomerular disease in humans o Advanced PhD post-doctoral fellows with training in biostatistics or translational research who seek advanced training in clinical research in human glomerular disease o Junior faculty with training similar to that noted above who are interested in establishing a career investigating glomerular disease in humans o Established investigators interested in refocusing their investigative path to include studies of glomerular disease in humans o Individuals must be specifically interested in training to do translational or clinical research. Translational research can be broadly interpreted to include laboratory or in silico investigations that can be directly applied to studying human glomerular disease. Examples of these types of investigations include but are not limited to identification of molecular biomarkers, studies involving techniques of human genetics, or studies involving generation or application of the tools of biostatistical modeling and epidemiological studies. o Applicants can come from Consortium participant institutions or elsewhere as long as trainee relocates to or is located in close physical proximity to a participant institution for training.
This training program is NOT intended for pre-doctoral candidates or junior level post-doctoral fellows.
• Training Program should have two components:
o Mentored research project with an established investigator conducting clinical or translational research in the area of or related to human glomerular disease; ideally, the trainee’s project should employ the unique infrastructure, clinical data, or specimens assembled by NEPTUNE
o Applicants are encouraged to create an individualized training program that would enhance their formal skills in clinical research design, statistics, etc. relevant to their intended investigative path. If appropriate, this might include formal class work, participation in ongoing seminar series, or other appropriate training. Consideration should be given to employing local resources to help defray the costs of this training.
• Requirements
o Applicants must devote a minimum of 50% effort to their training o Applicant institutions must provide written commitment to protecting trainee’s time and providing financial support of the applicant
• Funding
o A maximum of $60,000 per year to support salary and fringe benefits only o Duration of grant support will be a minimum of 1 and maximum of 2 years o In necessary, applicant institutions are encouraged to contribute to financial and other resources necessary for the success of the proposed training program; the use of CTSA funding and other institutional resources should be considered o Indirect Costs: no institutional overhead will be funded since this fellowship will be funded by Nephcure
The NephCure Foundation 15 Waterloo Ave Berwyn, PA 19312
1.866 NephCure (637-4287)
info@nephcure.org
National Parkinson Foundation 2011 Request for Applications
Individual grants will be limited to a maximum of $250,000 over a period of up to two years.
NPF is pleased to issue its yearly Request for Applications (“RFA”) with the goal of funding clinical investigations in several specific areas of Parkinson’s disease research led at NPF Centers of Excellence (“COE”) and Care Consortium Centers. This RFA will provide support for well-designed clinical research that addresses comparative effectiveness of treatment, current unmet needs, and/or clinical controversies. This RFA will fund programs based on scientific merit, as determined by the NPF’s Clinical and Scientific Advisory Board (“CSAB”) in a peer-review process.
Applications will be accepted from any principal investigator affiliated with a currently certified NPF COE or a member of the NPF Care Consortium (“Applicant” from an “Eligible Institution”). Investigators not from Eligible Institutions are invited to participate as collaborators. Total grant funding is dependent upon quality of applications.
The following are the key dates for this RFA:
Release date: August 12, 2010 Application deadline: December 10, 2010 at 6:00 p.m. EST Anticipated award announcement: On or before April 15, 2011
NATIONAL PARKINSON FOUNDATION, INC. 1501 N.W. 9th Avenue / Bob Hope Road Miami, Florida 33136-1494 Telephone: (305)243-6666 Toll Free National: 1-800-327-4545 Fax: (305)243-6073 E-mail inquiries: contact@parkinson.org
National Psoriasis Foundation Discovery Research Grant
The National Psoriasis Foundation is seeking grant applications that encourage the advancement of innovative research in psoriasis and psoriatic arthritis. Discovery Research Grants are intended to allow researchers to undertake preliminary and proof of concept studies with the goal of developing competitive grant proposals that lead to long-term funding from the National Institutes of Health or other federal agencies.
Research pathways: The National Psoriasis Foundation supports basic and clinical research that leads to the prevention, diagnosis and cure of psoriasis and psoriatic arthritis. Priority consideration will be given to applications that address one or more of the Foundation’s research pathways: (1) genetics, (2) cell biology, (3) immunology, and (4) epidemiological/health services research.
Anticipated number of awards: It is anticipated that as many as nine new Discovery Research Grants will be awarded in 2011. Awards are contingent on the availability of funds and the receipt of sufficiently meritorious applications.
Budget and Project period: Applicants may request up to $50,000 (direct costs only) per year. The total project period for the application submitted in response to this RFP is one year.
Research plan length: The research proposal cannot exceed five (5) pages including figures and tables, excluding references.
Eligibility: It is expected that the principal investigator will be personally and actively responsible for the conduct of the research and is considered eligible by his or her institution to apply for a research grant. The principal investigator need not be a United States citizen.
Important deadlines: The application must be received by Monday October 4th, 2010. The applications will be evaluated by an expert panel of peer reviewers and awards will be made no later than March 1, 2011.
Application: Completed applications should be converted to a single PDF file and submitted by email to: research@psoriasis.org.
Questions: For more information on the Discovery Research Grant program please contact the Director of Research, Bruce F. Bebo, Jr., PhD. Phone: 503-546-8404; E-mail: research@psoriasis.org.
National Psoriasis Foundation Translational Research Grant
The National Psoriasis Foundation is seeking grant applications that focus on the rapid translation of scientific discoveries arising from laboratory, clinical or population-based studies into clinical applications that have a clear benefit for patients with psoriasis and/or psoriatic arthritis.
Research pathways: Priority consideration will be given to applications that address one or more of the Foundation's research pathways: (1) genetics, (2) cell biology, (3) immunology, and (4) epidemiological/health services research.
Anticipated number of awards: It is anticipated that as many as four new Translational Research Grants will be awarded in 2011. Awards are contingent on the availability of funds and the receipt of sufficiently meritorious applications.
Budget and Project period: Applicants may request up to $100,000 (direct costs only) per year. The total project period for the application submitted in response to this RFP is two (2) years.
Research plan length: The research proposal must not exceed eight (8) pages, including figures and tables, excluding references.
Important deadlines: The applications must be received by Monday October 4, 2010. The applications will be evaluated by an expert panel of peer reviewers and awards will be made no later than March 1, 2011.
Application: Completed applications should be converted to a single PDF file and submitted by e-mail to: research@psoriasis.org.
Questions: For more information on the Translational Research grant program please contact the Director of Research, Bruce F. Bebo, Jr., PhD. Phone: 503-546-8404; E-mail: research@psoriasis.org.
Oncology Nursing Society Foundation Mara Mogensen Flaherty Memorial Lectureship Award
Supported by sanofi-aventis
Award: The lecturer receives a $2,000 honorarium, airfare to ONS Congress to present lecture, and two-day per diem expenses.
Purpose: The Mara Mogensen Flaherty Memorial Lectureship Award supports an annual lecture on a topic related to the psychosocial aspects of cancer diagnosis, treatment, and care presented by an individual who is involved in the field of psychosocial oncology, cancer care, education or research. The lecture is presented at the ONS Annual Congress.
Eligibility: Candidates for this award must be health care professionals, and may or may not be members of ONS. Candidates must agree to deliver a prepared 45-minute lecture during the ONS Annual Congress.
Although not an eligibility requirement of the award, recipients are encouraged to submit an article based on the lecture to ONS for publication. The decision to publish the article would fall within the ONS journal approval process for articles.
Application deadline: September 15, 2010
Oncology Nursing Society Foundation 125 Enterprise Drive Pittsburgh, PA 15275-1214 (412) 859-6100 (412) 859-6163 foundation@ons.org
Oncology Nursing Society Foundation Mentored Planning Grant Funding
Award: The Mentored Planning Grant award is $2,500.00 for development of a proposal for a Small Grant Award. The funding period is from March 15-October 1, at which time an application for a ONS Foundation Small Grant Award is due.
Purpose: The purpose of the ONS Foundation Mentored Planning Grant Award is to provide development support for new scientists. Funding supports a new investigator to work closely with an established researcher mentor to develop a research proposal. At the end of the funding period, an ONS Foundation Small Grant Application is submitted on October 1 for consideration of a $10,000 small grant award. If ONS Foundation Small Grant funding is received, the investigator and mentor must work together to implement the research study.
Eligibility: The principal investigator must be actively involved in some aspect of cancer patient care, education or research. Funding preference is given to projects that involve nurses in the design and conduct of the research activity and that promote theoretically based oncology practice. Membership in ONS is not required for eligibility. Both master's prepared and doctorally-prepared investigators may apply for this award; doctoral students are not eligible.
Application Deadline: November 15, 2010
Oncology Nursing Society Foundation Breast Cancer Research Grant
Supported by the ONS Foundation through an unrestricted grant from Susan G. Komen for the Cure®
Letters of Intent due: November 15, 2010
Online Applications due: December 15, 2010
Purpose: A major goal of the ONS Foundation is to provide funding to support the ONS Research Agenda. The agenda’s focus is on areas where gaps exist in the knowledge base for oncology nursing practice. Applications are invited for breast cancer grant proposals that address high-priority topic areas identified by the 2009 – 2013 ONS Research Agenda.
Only proposals addressing breast cancer will be considered for funding. The 2009–2013 ONS Research Agenda identifies critical areas where research is needed to advance the science and practice of oncology nursing.
Award: One $60,000 grant award with a funding period of up to two years with NO "no-cost" extensions possible. Funding will be distributed for each year of the grant – up to $30,000 for year one and up to $30,000 for year two. Please submit your detailed budget for each year. First year funding will be available by February 2011.
Eligibility: The principal investigator must be actively involved in some aspect of cancer patient care, education, or research. Funding preference is given to projects that involve nurses in the design and conduct of the research activity. Membership in ONS is not required for eligibility. ONS Foundation encourages advanced practice nurse (APN) and researcher partnerships. For an APN PI to be considered for funding the research team must include both an APN and researcher.
If you have further questions, please contact the ONS Research Team at research@ons.org
Oncology Nursing Society Trish Greene Memorial Quality of Life Lectureship
Award: A $2,000 honorarium, one coach airfare to IOL, two-day per diem for IOL, and a plaque. The paper will be published in the Clinical Journal of Oncology Nursing.
Purpose: This award was established to focus attention of the membership on quality-of-life issues in cancer care; describe the contributions of clinicians, educators, administrators, and researchers in oncology nursing to quality of life in cancer care; apply information related to quality of life to oncology nursing practice; and incorporate the philosophy of quality of life into all aspects of cancer care. The lecture is presented at the ONS Annual Institutes of Learning.
This award is named in memory of Trish Greene, a pioneer in oncology nursing and a leader within the ONS, ACS, UICC, and Leukemia Society of America, as well as being a founding member and the first president of APON. As pain management expert, she was committed to ensuring quality, compassionate care for patients with cancer.
Nominee's Eligibility Criteria: The candidate must meet the following criteria:
Be a registered professional nurse and an active ONS member Demonstrate excellence in clinical practice, education, administration, or research related to quality-of-life issues and contribute to the specialty of oncology nursing Communicate effectively through written and verbal formats.
Criteria: The scoring criteria for judging this nomination packet is as follows:
ONS involvement: Participation should include involvement at the local or national level, and includes membership on committees, holding office, or task force participation. Contribution to the specialty of Oncology Nursing: Examples from CV Clinical developments such as staff development, program development, patient teaching, support groups Community outreach (programs such as ACS, Leukemia Society, camps for patients with cancer, survivor's day participation or other related activities) Adjunct faculty or preceptor of students Excellent written communication skills: Includes articles in newsletters, journals, reports, video, multimedia, computer assisted instruction, or chapters in books Presentation experience: Presentations listed on CV/application Excellence in Quality of Life Issues (Clinical, education, administration and/or research related): Examples within reference letters or on CV QOL contributions: presentations, literature, specific educational interventions, research issues
Application deadline: October 31, 5pm ET.
Oncology Nursing Society 125 Enterprise Drive Pittsburgh, PA 15275
866-257-4ONS (866-257-4667) 412-859-6100 877-369-5497 (toll free fax) 412-859-6162 (fax) customer.service@ons.org
Oncology Nursing Society Clinical Lectureship
Award: A $2,000 honorarium, one coach airfare to ONS Annual Congress, two-day per diem for Congress, and a plaque. The paper is published in the September issue of the Oncology Nursing Forum.
Purpose: To recognize and support excellence in clinical nursing practice. The lecture is presented at the ONS Annual Congress.
Be a registered professional nurse and an active ONS member Have a minimum of two years experience in oncology nursing Be a recognized expert in clinical nursing practice because of his or her contributions to the development of oncology nursing
ONS involvement: Participation should include involvement at the local or national level, and includes membership on committees, holding office, or task force participation. The nominee's clinical practice is consistent with the ONS Scope of Oncology Nursing Practice and demonstrates the use of the following criteria: Use of theoretical concepts Use of the nursing process Professional development of self and other Multidisciplinary collaboration Quality assurance Uses ethical decision making Reviews and applies research into practice (Examples of actual patient contacts, examples of actual patient experiences provided by patients within the reference letters, Clinical practice nursing research, Topics, lectures, a model or theory, developed standards of care, published a model/theory) The nominee is an effective communicator: Examples within reference letters Presentations listed on CV well written based on the conference Clinical practice contribution to literature: Includes articles in newsletters, journals, reports, video, multimedia, computer assisted instruction, or chapters in books Contribution to the development of the oncology nursing practice: Examples within reference letters or on CV Clinical developments such as staff development, program development, patient teaching, support groups Community outreach (Programs such as ACS, Leukemia Society, camps for patients with cancer, survivor's day participation or other related activities Adjunct faculty or preceptor of students) The clinical topic is relevant to membership at large, well written, concerns a current educational need and/or new trend.
1234567891011...14next